According to Hikma Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is โน268.89 Billion. In 2024 the company made a revenue of โน268.89 Billion an increase over the revenue in the year 2023 that were of โน247.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน268.89 B | 8.77% |
2023 | โน247.22 B | 14.22% |
2022 | โน216.43 B | -1.41% |
2021 | โน219.53 B | 9.06% |
2020 | โน201.30 B | 6.07% |
2019 | โน189.77 B | 6.62% |
2018 | โน177.99 B | 6.92% |
2017 | โน166.47 B | -0.72% |
2016 | โน167.68 B | 35.42% |
2015 | โน123.82 B | -3.29% |
2014 | โน128.03 B | 9.08% |
2013 | โน117.37 B | 23.08% |
2012 | โน95.36 B | 20.8% |
2011 | โน78.94 B | 25.6% |
2010 | โน62.85 B | 14.77% |
2009 | โน54.76 B | 9.68% |
2008 | โน49.93 B | 29.38% |
2007 | โน38.59 B | 41.57% |
2006 | โน27.26 B | 20.9% |
2005 | โน22.54 B | 23.47% |
2004 | โน18.26 B | 101.98% |
2003 | โน9.04 B | 22.98% |
2002 | โน7.35 B |